About
Cayuga Biotech develops therapeutics that use the body's innate hemostatic mechanisms to treat life-threatening hemorrhage and bleeding disorders, including noncompressible hemorrhage and coagulation dysfunction caused by platelet inhibitors.
Explore Cayuga Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.